MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress » Parkinsonism, Atypical: PSP, CBD

Meeting: 2024 International Congress

18F-Florzolotau Positron Emission Tomography Imaging Correlates with Regional Brain Atrophy and Plasma Biomarkers in Tauopathy Parkinsonism Syndrome

CH. Li, SP. Fan, MC. Shih, YH. Weng, TF. Chen, IT. Hsiao, KJ. Lin, CH. Lin (Hsinchu, Taiwan)

Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)

Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)

Clinical and neuroimaging factors associated with survival in Progressive Supranuclear Palsy

G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, L. van Bommel, S. Meles, M. Riverol, KL. Leenders, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

Clinical characteristics and Brain atrophy pattern in the prospective multicenter cohort of Progressive Supranuclear Palsy

S. Lee, R. Kim, B. Jin, H. Kim, EJ. Yoon, YK. Kim, JH. Shin, HJ. Kim, JY. Lee (Seoul, Republic of Korea)

Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)

Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies

A. Jäck, W. Wilfert, C. Palleis, A. Bernhardt, E. Weidinger, S. Katzdobler, U. Fietzek, D. Teupser, J. Levin (Munich, Germany)

Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism

M. Acharya (Kharagpur, India)

Dermal 4R-Tau seeding as a novel biomarker for Progressive Supranuclear Palsy

I. Martinez-Valbuena, D. Olszewska, M. Sousa, T. Abkur, N. Bendahan, N. Reyes, M. Emamikhah Abarghouei, C. Ghadery, L. Armengou Garcia, J. Liao, C. Tan, SM. Fereshtehnejad, H. Alotibi, JC. Vargas-Gonzalez, NC. Dimal, J. Li, P. Bhakta, R. Cheung, J. Sasitharan, N. Visanji, S. Fox, C. Tartaglia, A. Lang, G. Kovacs (Toronto, Canada)

Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies

I. Ruiz Barrio, A. Horta Barba, A. Puig Davi, I. Aracil Bolaños, A. Quattrone, S. Martinez Horta, J. Kulisevksy, J. Pagonabarraga (Barcelona, Spain)

Diagnostic Spectrum in a Cohort of Atypical Atypical Parkinsonism

P. Katragadda, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

Early Syndromes and Clinicopathologic Progression in Progressive Supranuclear Palsy

D. Ono, H. Sekiya, N. Ghayal, A. Maier, S. Roemer, D. Dickson (Jacksonville, USA)

Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)

Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy

I. Kamacı, B. Marangozoglu Samanci, B. Zorlu Ucuncuoglu, E. Sahin, B. Bilgin, H. Hanağası (Istanbul, Turkey)

Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity

A. Premkumar, D. Lim, SK. Seetharaman, LF. Tan (Singapore, Singapore)

Identification of underlying Lewy body pathology in primary tauopathies by α-synuclein seed amplification assay

L. Concha-Marambio, C. Farris, S. Weber, Y. Ma, T. Tropea, D. Irwin, A. Siderowf, B. Mollenhauer (san diego, USA)

Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

Is cathepsin D a good target for therapy in Tau-related conditions?

G. Kovacs, A. Jafrani, G. Puska, I. Martinez-Valbuena, S. Lee, S. Knott, A. Karakani, S. Tanikawa, A. Lang, S. Forrest (Toronto, Canada)

Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment

D. Taniguchi, T. Hatano, Y. Imai, N. Hattori (Tokyo, Japan)

Longitudinal progress and clinical relevance of 18F-Florzolutau PET in patients with PSP: a one-year follow-up study

J. Wang, F. Liu, C. Zuo (Shanghai, China)

Metabolic Covariance Networks in Progressive Supranuclear Palsy Revealed by Spatial independent component analysis

B. Wang, H. Wang, W. Luo (Hangzhou, China)

Metabolic Progressive Subtypes in Progressive Supranuclear Palsy

H. Wang (Hangzhou, China)

Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia

V. Martínez-Villota, L. Ortega-Bolaños, C. Hurtado-Gonzalez (Pasto, Colombia)

Nigral Neuroinflammation and Dopaminergic Neurons in PD, MSA and PSP: A Comparative Clinicopathological Study

E. Backman, M. Gardberg, L. Luntamo, M. Peurla, T. Vahlberg, P. Borghammer, N. Stefanova, G. Wenning, V. Kaasinen (Turku, Finland)

Paraneoplastic neurological syndrome mimicking a progressive supranuclear palsy: a case series

R. Zouari, F. Nabli, A. Rachdi, D. Ben Mohamed, MZ. Saeid, S. Ben Sassi (Tunis, Tunisia)

Peripheral immune profile and neutrophil-to-lymphocyte ratio in Progressive Supranuclear Palsy

L. Muñoz-Delgado, A. Luque-Ambrosiani, B. Benítez Zamora, D. Macías-García, S. Jesús, AD. Adarmes‐gómez, E. Ojeda-Lepe, F. Carrillo, P. Mir (Sevilla, Spain)

Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)

Pisa Syndrome as an early presenting feature of Corticobasal Ganglionic degeneration [CBGD]

M. Matta, N. Sawal, A. Prasad (Chandigarh, India)

Progressive freezing of gait in atypical parkinsonism. A Possible Progressive Supranuclear Palsy phenotype.

H. Pacheco Mendoza, L. Nuñez Orozco, A. Negrete Gomez, J. Delgado Uriarte, C. Gómez Rubio (Mexico, Mexico)

PSP: a Clinical Case

K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)

Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

Regional tau burden patterns and their associations with clinical severity in progressive supranuclear palsy (PSP)-Richardson’s syndrome and PSP- predominant parkinsonism: a prospective cohort study

R. Kim, S. Lee, Y. Kim, B. Jin, S. Kim, H. Kim, S. Shin, H. Kim, J. Lee (Seoul, Republic of Korea)

Remote Digital Longitudinal Assessment of Speech, Fluency and Cognitive Function in Progressive Supranuclear Palsy

A-M. Wills, R. Mishra, M. Sharma, V. Zhao, C. Isroff, AJ. Hall, J. Casado, A. Nunes, R. Cole, A. Vaziri, A. Pantelyat (Boston, USA)

Spectrum of Sleep abnormalities in Patients with Progressive supranuclear palsy

M. Nanjunda Swamy, S. Dey, N. Kamble, V. Holla, R. Mahale, P. Pal, M. Debnath, R. Yadav (Bengaluru, India)

Stiff Person Syndrome developing into Corticobasal Syndrome: a case report.

M. Costa, D. Boone, C. Silva, B. Veiga, R. Novais, L. Barcelos, R. Saba, V. Borges, H. Ferraz (São Paulo, Brazil)

Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.

X. Li, FT. Liu (Shanghai, China)

The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

The Landscape of Interdisciplinary Care for Atypical Parkinsonism: A Qualitative Study from the CurePSP Centers of Care

D. Shpiner, J. Shurer, F. Ali, M. Barrett, A. Brown, A. Duquette, J. Fleisher, G. Lamotte, A. Pantelyat, S. Reichwein, F. Rodriguez-Porcel, J. Siddiqui, M. Sklerov, C. Spears, T. Virmani, R. Akhtar (Miami, USA)

The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy

P. Alster, D. Otto-ślusarczyk, A. Drzewińska, K. Duszyńska-Wąs, A. Wiercińska-Drapało, M. Struga, N. Madetko-Alster (Warszawa, Poland)

Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy

A. Blazek, C. Hogen, J. Whitwell, K. Josephs, K. Kaufman, F. Ali (Rochester, USA)

Video-oculography for enhancing the diagnostic accuracy of early oculomotor dysfunction in Progressive Supranuclear Palsy

H. Chovatiya, K. Pillai, C. Reddy, A. Prabhu, A. Thalakkattu, A. Avarachan, M. Chacko, A. Kishore (Kochi, India)

« View all sessions from the 2024 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley